UP!
| Period | Date | Adjusted Actuals EPS | GAAP EPS |
|---|---|---|---|
| Q3 2022 | 2022-11-07 | Future report Set alerts | |
| Q2 2022 | 2022-08-08 | -0.59 | -0.59 |
| Q1 2022 | 2022-05-05 | -0.49 | -0.49 |
| Q4 2021 | 2022-02-28 | -0.43 | -0.43 |
| Q3 2021 | 2021-11-09 | -0.45 | -0.45 |
| Q2 2021 | 2021-08-05 | -0.34 | -0.34 |
| Q1 2021 | 2021-05-06 | 0.00 | 0.00 |
| Q4 2020 | 2021-03-29 | 0.00 | 0.00 |
| Q3 2020 | 2020-11-05 | -0.36 | -0.36 |
| Q2 2020 | 2020-08-06 | -0.50 | -0.50 |
| 2016-06-07 | Reiterated Rating | Cowen and Company | Outperform | $12.00 |
| 2016-05-06 | Reiterated Rating | Wedbush | Neutral | $3.00 |
| 2016-05-06 | Reiterated Rating | Jefferies Group | Hold | $4.00 |
| 2016-04-19 | Reiterated Rating | Cowen and Company | Outperform | $12.00 |
| 2016-04-19 | Reiterated Rating | Roth Capital | Buy | $7.00 |
| 2016-03-08 | Reiterated Rating | Roth Capital | Buy | |
| 2016-03-08 | Reiterated Rating | Brean Capital | Buy | $24.00 |
| 2016-03-08 | Lower Price Target | HC Wainwright | Buy | $25.00 to $6.00 |
| 2016-03-08 | Reiterated Rating | Cowen and Company | Outperform | $28.00 to $12.00 |
| 2016-03-07 | Downgrade | Leerink Partner | Outperform to Market Perform | |
| 2016-03-07 | Downgrade | Jefferies Group | Buy to Hold | $31.00 to $4.00 |
| 2016-03-07 | Downgrade | Leerink Swann | Outperform to Market Perform | $30.00 to $4.00 |
| 2016-03-07 | Downgrade | Wedbush | Outperform to Neutral | $4.00 |
| 2016-03-07 | Downgrade | Oppenheimer | Outperform to Market Perform | |
| 2016-03-07 | Downgrade | Guggenheim | Buy to Neutral | |
| 2016-03-07 | Downgrade | Oppenheimer Holdings Inc. | Outperform to Market Perform | |
| 2016-03-01 | Initiated Coverage | HC Wainwright | Buy | $25.00 |
| 2016-02-26 | Lower Price Target | Cantor Fitzgerald | Buy | $31.00 to $25.00 |
| 2016-02-25 | Reiterated Rating | Wedbush | Outperform | $24.00 |
| 2015-11-24 | Initiated Coverage | Roth Capital | $39.00 | |
| 2015-11-09 | Reiterated Rating | Brean Capital | Buy | $31.00 |
| 2015-09-15 | Reiterated Rating | Cowen and Company | Buy | $28.00 |
| 2015-08-27 | Reiterated Rating | Roth Capital | Buy | |
| 2015-08-14 | Reiterated Rating | Leerink Swann | Outperform | $45.00 |
| 2015-08-11 | Reiterated Rating | Cowen and Company | Outperform | $34.00 to $28.00 |
| 2015-08-11 | Lower Price Target | Cantor Fitzgerald | Buy | $38.00 to $31.00 |
| 2015-08-11 | Lower Price Target | Oppenheimer | Outperform | $45.00 to $42.00 |
| 2015-08-11 | Lower Price Target | Brean Capital | Buy | $35.00 to $31.00 |
| 2015-08-11 | Lower Price Target | Roth Capital | Buy | $43.00 to $39.00 |
| 2015-06-30 | Reiterated Rating | Oppenheimer | Buy | $45.00 |
| 2015-06-30 | Reiterated Rating | Roth Capital | Buy | $43.00 |
| 2015-06-02 | Reiterated Rating | Brean Capital | Buy | $35.00 |
| 2015-06-02 | Reiterated Rating | Cantor Fitzgerald | Buy | $38.00 |
| 2015-06-01 | Reiterated Rating | WBB Securities | Buy | $30.00 to $40.00 |
| 2015-06-01 | Set Price Target | Cowen and Company | Buy | $33.00 to $34.00 |
| 2015-05-05 | Reiterated Rating | Cantor Fitzgerald | Buy | $38.00 |
| 2015-03-18 | Reiterated Rating | Jefferies Group | Buy | $24.00 to $36.00 |
| 2015-03-11 | Boost Price Target | Cantor Fitzgerald | Buy | $33.00 to $38.00 |
| 2015-02-23 | Set Price Target | Cowen and Company | Buy | $26.00 |
| 2014-12-19 | Set Price Target | Cantor Fitzgerald | Buy | $33.00 |
| 2014-11-17 | Reiterated | ROTH Capital | Buy | $40 to $43 |
| 2014-11-17 | Reiterated Rating | Oppenheimer | $36.00 | |
| 2014-11-17 | Boost Price Target | Roth Capital | Buy | $40.00 to $43.00 |
| 2014-09-26 | Initiated Coverage | Cowen and Company | Outperform | $22.00 |
| 2014-04-28 | Upgrade | Ned Davis Research | Sell to Neutral | |
| 2014-03-04 | Boost Price Target | Jefferies Group | Buy | $29.00 to $31.00 |
| 2014-03-04 | Reiterated Rating | Cantor Fitzgerald | Buy | $39.00 to $33.00 |
| 2014-03-04 | Lower Price Target | Oppenheimer | Outperform | $40.00 to $36.00 |
| 2013-11-07 | Reiterated Rating | Brean Capital | Buy | |
| 2013-10-22 | Reiterated Rating | Oppenheimer | Buy | $40.00 |
| 2013-10-22 | Reiterated Rating | Cantor Fitzgerald | Buy | $39.00 |
| 2013-10-22 | Boost Price Target | Roth Capital | Buy | $34.00 to $40.00 |
| 2013-10-07 | Initiated Coverage | Ned Davis Research | Neutral | |
| 2013-10-02 | Reiterated Rating | Cantor Fitzgerald | Buy | $39.00 |
| 2013-10-02 | Boost Price Target | Oppenheimer | $40.00 | |
| 2013-09-24 | Boost Price Target | Guggenheim | Buy | $26.00 to $34.00 |
| 2013-09-24 | Boost Price Target | Cantor Fitzgerald | Buy | $39.00 |
| 2013-09-23 | Boost Price Target | Leerink Swann | Outperform | $28.00 to $45.00 |
| 2013-09-17 | Reiterated Rating | Wedbush | Buy | $35.00 |
| 2013-09-17 | Boost Price Target | Jefferies Group | Buy | $25.00 to $29.00 |
| 2013-07-08 | Reiterated | Cantor Fitzgerald | Buy | $16 to $24 |
| 2013-03-08 | Reiterated | Cantor Fitzgerald | Buy | $13 to $16 |
| 2013-01-10 | Reiterated | Cantor Fitzgerald | Buy | $9 to $13 |
| 2012-09-14 | Reiterated | Cantor Fitzgerald | Buy | $7 to $9 |
| 2012-04-04 | Initiated | Cantor Fitzgerald | Buy | $7 |
| 2011-11-02 | Reiterated | Brean Murray | Buy | $16 to $14 |
| 2010-05-05 | Reiterated | WBB Securities | Strong Buy | $10 to $15 |
| 2009-09-29 | Initiated | WBB Securities | Strong Buy | $10 |
| 2008-12-19 | Reiterated | Brean Murray | Buy | $19 to $16 |
| 2008-10-24 | Initiated | Merriman Curhan Ford | Buy |
| 2016-06-07 | Reiterated Rating | Cowen and Company | Outperform | $12.00 |
| 2016-05-06 | Reiterated Rating | Wedbush | Neutral | $3.00 |
| 2016-05-06 | Reiterated Rating | Jefferies Group | Hold | $4.00 |
| 2016-04-19 | Reiterated Rating | Cowen and Company | Outperform | $12.00 |
| 2016-04-19 | Reiterated Rating | Roth Capital | Buy | $7.00 |
There is presents forecasts of rating agencies and recommendations for investors about this ticker
In CLDX 123 funds of 2213 total. Show all
| Fund name | Ticker shares |
|---|---|
| COLUMBIA WANGER ASSET MANAGEMENT LLC | 10.77M |
| FMR LLC | 7.02M |
| BlackRock Fund Advisors | 4.59M |
| STATE STREET CORP | 3.17M |
| BlackRock Inc. | 3.13M |
| RTW INVESTMENTS, LLC | 3.08M |
| WELLINGTON MANAGEMENT CO LLP | 3.08M |
| BlackRock Institutional Trust Company, N.A. | 2.74M |
| Vanguard Group, Inc | 2.48M |
| RA CAPITAL MANAGEMENT, LLC | 2.08M |
| Redmile Group, LLC | 1.99M |
| EVENTIDE ASSET MANAGEMENT, LLC | 1.79M |
| CITADEL ADVISORS LLC | 1.58M |
| JENNISON ASSOCIATES LLC | 1.27M |
| GEODE CAPITAL MANAGEMENT, LLC | 0.85M |
| Name Relationship | Total Shares | Holding stocks |
|---|---|---|
| MEDAREX INC | 3.31% (2960848) | CLDX / |
| van den Broek Richard | 0.26% (233500) | CLDX / PCYC / RGDX / |
| McMahon Gerald PhD | 0.22% (200549) | CLDX / OXGN / |
| SHANNON TIMOTHY M | 0.09% (83212) | CLDX / |
| CATLIN AVERY W Sr. VP & CFO | 0.08% (73586) | CLDX / |
| ELLBERGER LARRY | 0.08% (73500) | CLDX / |
| Marucci Anthony S President & CEO | 0.06% (50028) | CLDX / |
| PENNER HARRY JR | 0.05% (41916) | CLDX / |
| LIPTON KAREN SHOOS | 0.05% (41833) | CLDX / |
| CONRAD HERBERT J | 0.04% (38500) | CLDX / TKMR / |
| Elston George | 0.03% (28500) | CBRX / CLDX / |
| MARINO JAMES J | 0.03% (25997) | CLDX / ONTX / |
| KELER TIBOR Sr. VP & CSO | 0.02% (15868) | CLDX / |
| Brownlie Keith L | 0.01% (10000) | CGIX / CLDX / IMNP / RXII / SNGX / |
| Newbold Ronald C Sr. VP, Business Dev. | 0.01% (5868) | CLDX / |
| SCHALLER CHARLES R | 0.01% (5000) | CLDX / |
UM